These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Kaposi's sarcoma-associated herpesvirus-encoded LANA contributes to viral latent replication by activating phosphorylation of survivin. Lu J; Jha HC; Verma SC; Sun Z; Banerjee S; Dzeng R; Robertson ES J Virol; 2014 Apr; 88(8):4204-17. PubMed ID: 24478433 [TBL] [Abstract][Full Text] [Related]
3. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression. Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248 [TBL] [Abstract][Full Text] [Related]
4. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication. Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712 [TBL] [Abstract][Full Text] [Related]
5. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications. Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ mBio; 2018 May; 9(3):. PubMed ID: 29739902 [TBL] [Abstract][Full Text] [Related]
6. KSHV Genome Replication and Maintenance in Latency. Ueda K Adv Exp Med Biol; 2018; 1045():299-320. PubMed ID: 29896673 [TBL] [Abstract][Full Text] [Related]
7. The Expression and Nuclear Retention Element of Polyadenylated Nuclear RNA Is Not Required for Productive Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus. Gutierrez IV; Dayton J; Harger S; Rossetto CC J Virol; 2021 Jun; 95(13):e0009621. PubMed ID: 33853955 [TBL] [Abstract][Full Text] [Related]
8. Site-specific association with host and viral chromatin by Kaposi's sarcoma-associated herpesvirus LANA and its reversal during lytic reactivation. Mercier A; Arias C; Madrid AS; Holdorf MM; Ganem D J Virol; 2014 Jun; 88(12):6762-77. PubMed ID: 24696474 [TBL] [Abstract][Full Text] [Related]
9. Kaposi's sarcoma-associated herpesvirus-encoded LANA interacts with host KAP1 to facilitate establishment of viral latency. Sun R; Liang D; Gao Y; Lan K J Virol; 2014 Jul; 88(13):7331-44. PubMed ID: 24741090 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jκ. Zhang L; Zhu C; Guo Y; Wei F; Lu J; Qin J; Banerjee S; Wang J; Shang H; Verma SC; Yuan Z; Robertson ES; Cai Q J Virol; 2014 Jun; 88(12):6873-84. PubMed ID: 24696491 [TBL] [Abstract][Full Text] [Related]
11. Reduction of Kaposi's Sarcoma-Associated Herpesvirus Latency Using CRISPR-Cas9 To Edit the Latency-Associated Nuclear Antigen Gene. Tso FY; West JT; Wood C J Virol; 2019 Apr; 93(7):. PubMed ID: 30651362 [TBL] [Abstract][Full Text] [Related]
12. Regulation of KSHV Latency and Lytic Reactivation. Broussard G; Damania B Viruses; 2020 Sep; 12(9):. PubMed ID: 32957532 [TBL] [Abstract][Full Text] [Related]
13. KSHV reactivation from latency requires Pim-1 and Pim-3 kinases to inactivate the latency-associated nuclear antigen LANA. Cheng F; Weidner-Glunde M; Varjosalo M; Rainio EM; Lehtonen A; Schulz TF; Koskinen PJ; Taipale J; Ojala PM PLoS Pathog; 2009 Mar; 5(3):e1000324. PubMed ID: 19266083 [TBL] [Abstract][Full Text] [Related]
14. Sirtuin 6 Attenuates Kaposi's Sarcoma-Associated Herpesvirus Reactivation by Suppressing Ori-Lyt Activity and Expression of RTA. Hu M; Armstrong N; Seto E; Li W; Zhu F; Wang PC; Tang Q J Virol; 2019 Apr; 93(7):. PubMed ID: 30651359 [TBL] [Abstract][Full Text] [Related]
15. Kaposi Sarcoma Herpesvirus (KSHV) Latency-Associated Nuclear Antigen (LANA) recruits components of the MRN (Mre11-Rad50-NBS1) repair complex to modulate an innate immune signaling pathway and viral latency. Mariggiò G; Koch S; Zhang G; Weidner-Glunde M; Rückert J; Kati S; Santag S; Schulz TF PLoS Pathog; 2017 Apr; 13(4):e1006335. PubMed ID: 28430817 [TBL] [Abstract][Full Text] [Related]
16. Effects of the NEDD8-Activating Enzyme Inhibitor MLN4924 on Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus. Chang PJ; Chen LW; Chen LY; Hung CH; Shih YJ; Wang SS J Virol; 2017 Oct; 91(19):. PubMed ID: 28701396 [TBL] [Abstract][Full Text] [Related]
17. The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency. Lin X; Sun R; Zhang F; Gao Y; Bin L; Lan K J Virol; 2017 Sep; 91(17):. PubMed ID: 28615201 [TBL] [Abstract][Full Text] [Related]
18. The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi's sarcoma-associated herpesvirus latency during primary infection. Lu J; Verma SC; Cai Q; Robertson ES J Virol; 2011 Jul; 85(13):6148-61. PubMed ID: 21507979 [TBL] [Abstract][Full Text] [Related]
19. BET-Inhibitors Disrupt Rad21-Dependent Conformational Control of KSHV Latency. Chen HS; De Leo A; Wang Z; Kerekovic A; Hills R; Lieberman PM PLoS Pathog; 2017 Jan; 13(1):e1006100. PubMed ID: 28107481 [TBL] [Abstract][Full Text] [Related]
20. Nuclear Localization and Cleavage of STAT6 Is Induced by Kaposi's Sarcoma-Associated Herpesvirus for Viral Latency. Wang C; Zhu C; Wei F; Gao S; Zhang L; Li Y; Feng Y; Tong Y; Xu J; Wang B; Yuan Z; Robertson ES; Cai Q PLoS Pathog; 2017 Jan; 13(1):e1006124. PubMed ID: 28099521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]